Viewing Study NCT04664959


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-03-01 @ 12:04 PM
Study NCT ID: NCT04664959
Status: COMPLETED
Last Update Posted: 2025-02-04
First Post: 2020-12-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
Sponsor: Samsung Bioepis Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postmenopausal Osteoporosis View
Keywords: